FP163
4686
Dr.Vardhineedi Satya Amrita
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 4686 | Dr.Vardhineedi Satya Amrita | dramritaditya@gmail.com | 8489632361 |
Glaucoma
“Small Tube, Big Impact: Early Clinical Experience with ACP ST 250”
Ahmed Clear Path ST 250 is novel GDD with limited data.To evaluate its clinical outcomes in refractory glaucoma.Prospective interventional case series of 20 eyes for 5 months at 2 centers.Outcomes measures: reduction in IOP,medication burden,BCVA.Mean follow up period: 9.6 weeks (0.5-19). Mean Pre-& Postop IOP: 29.45+/-9.33mmHg & 15.45+/-5.61mmHg, with average reduction of 14(5 -30)mmHg (P<0.0001). Mean number of antiglaucoma medications reduced from Preop 3.80+/-1.32 to Postop 0.8+/-0.95, on an average 4 drugs to <1 drug(P=0.0001). BCVA ranged from 1.02+/-1.00 Preop to 1.01+/-1.01 Postop(P=0.5754).No significant complication, except self-limiting hypotony noted in 1 eye.6 eyes needed Supramid suture removal following which mean IOP reduction of 9.8 (1–22) mmHg was noted. Complete success was achieved in 50% eyes, qualified success in 35%, failure in 15%. ACP ST 250 is a safe device for effective IOP control, reshaping the trajectory of refractory glaucoma management.
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 530 | Dr.Gowri Jayadev Murthy | gowrijmurthy@gmail.com | 919886840172 |
| 2274 | Dr.Priyanka Sudhakar | priyanka89.vims@gmail.com | 9035106537 |
| 2321 | Dr.Meghana Hiremath | meghana.rh@gmail.com | 9986746540 |